{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:05:14Z","timestamp":1792422314603,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:00:00Z","timestamp":1558569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:00:00Z","timestamp":1558569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00125-019-4895-0","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:08:53Z","timestamp":1558624133000},"page":"1385-1390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5045-5351","authenticated-orcid":false,"given":"Dorte","family":"Vistisen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Kivim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Perreault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Hulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Tab\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit E.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"F\u00e6rch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,23]]},"reference":[{"key":"4895_CR1","doi-asserted-by":"crossref","unstructured":"Huang Y, Cai X, Mai W, Li M, Hu Y (2016) Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ 355:i5953","DOI":"10.1136\/bmj.i5953"},{"issue":"4","key":"4895_CR2","doi-asserted-by":"publisher","first-page":"899","DOI":"10.2337\/dc17-2530","volume":"41","author":"D Vistisen","year":"2018","unstructured":"Vistisen D, Witte DR, Brunner EJ, Kivimaki M, Tabak A, Jorgensen ME et al (2018) Risk of cardiovascular disease and death in individuals with prediabetes defined by different criteria: the Whitehall II study. Diabetes Care 41(4):899\u2013906. \n                    https:\/\/doi.org\/10.2337\/dc17-2530","journal-title":"Diabetes Care"},{"issue":"9833","key":"4895_CR3","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1016\/S0140-6736(12)60525-X","volume":"379","author":"L Perreault","year":"2012","unstructured":"Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE (2012) Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet. 379(9833):2243\u20132251. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(12)60525-X","journal-title":"Lancet."},{"issue":"9682","key":"4895_CR4","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(09)60619-X","volume":"373","author":"AG Tab\u00e1k","year":"2009","unstructured":"Tab\u00e1k AG, Jokela M, Akbaraly TN, Brunner EJ, Kivim\u00e4ki M, Witte DR (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373(9682):2215\u20132221. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(09)60619-X","journal-title":"Lancet"},{"key":"4895_CR5","doi-asserted-by":"publisher","unstructured":"American Diabetes Association (2018) Classification and diagnosis of diabetes. Sec. 2. In standards of medical care in diabetes - 2018. Diabetes Care 41(Suppl 1):S13\u2013S27. \n                    https:\/\/doi.org\/10.2337\/dc18-S002","DOI":"10.2337\/dc18-S002"},{"issue":"7","key":"4895_CR6","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.2337\/dc09-9033","volume":"32","author":"DM Nathan","year":"2009","unstructured":"Nathan DM, Balkau B, Bonora E, Borch-Johnsen K, Buse JB, Colagiuri S et al (2009) International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32(7):1327\u20131334","journal-title":"Diabetes Care"},{"issue":"6","key":"4895_CR7","doi-asserted-by":"publisher","first-page":"988","DOI":"10.2337\/dc15-2752","volume":"39","author":"J Cobb","year":"2016","unstructured":"Cobb J, Eckhart A, Motsinger-Reif A, Carr B, Groop L, Ferrannini E (2016) \u03b1-Hydroxybutyric acid is a selective metabolite biomarker of impaired glucose tolerance. Diabetes Care 39(6):988\u2013995. \n                    https:\/\/doi.org\/10.2337\/dc15-2752","journal-title":"Diabetes Care"},{"key":"4895_CR8","doi-asserted-by":"publisher","unstructured":"Babbar R, Heni M, Peter A et al (2018) Prediction of glucose tolerance without an oral glucose tolerance test. Front Endocrinol 9(82). \n                    https:\/\/doi.org\/10.3389\/fendo.2018.00082","DOI":"10.3389\/fendo.2018.00082"},{"issue":"9","key":"4895_CR9","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.2337\/dc14-0656","volume":"37","author":"L Perreault","year":"2014","unstructured":"Perreault L, Temprosa M, Mather KJ, Horton E, Kitabchi A, Larkin M et al (2014) Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program Outcomes Study. Diabetes Care 37(9):2622\u20132631. \n                    https:\/\/doi.org\/10.2337\/dc14-0656","journal-title":"Diabetes Care"},{"issue":"8","key":"4895_CR10","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1007\/s001250051249","volume":"42","author":"F de Vegt","year":"1999","unstructured":"de Vegt F, Dekker JM, Ruhe HG, Stehouwer CD, Nijpels G, Bouter LM et al (1999) Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn study. Diabetologia. 42(8):926\u2013931. \n                    https:\/\/doi.org\/10.1007\/s001250051249","journal-title":"Diabetologia."},{"issue":"1","key":"4895_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/1573399811666150416122903","volume":"12","author":"K Faerch","year":"2016","unstructured":"Faerch K, Hulman A, Solomon TP (2016) Heterogeneity of pre-diabetes and type 2 diabetes: implications for prediction, prevention and treatment responsiveness. Curr Diabetes Rev 12(1):30\u201341","journal-title":"Curr Diabetes Rev"},{"key":"4895_CR12","first-page":"Cd012661","volume":"10","author":"B Richter","year":"2018","unstructured":"Richter B, Hemmingsen B, Metzendorf MI, Takwoingi Y (2018) Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia. Cochrane Database Syst Rev 10:Cd012661","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"4895_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41387-018-0047-8","volume":"8","author":"K Faerch","year":"2018","unstructured":"Faerch K, Alssema M, Mela DJ, Borg R, Vistisen D (2018) Relative contributions of preprandial and postprandial glucose exposures, glycemic variability, and non-glycemic factors to HbA 1c in individuals with and without diabetes. Nutr Diabetes 8(1):38. \n                    https:\/\/doi.org\/10.1038\/s41387-018-0047-8","journal-title":"Nutr Diabetes"},{"issue":"2","key":"4895_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1001\/jama.2013.283127","volume":"311","author":"Kristine F\u00e6rch","year":"2014","unstructured":"Faerch K, Vistisen D (2014) Prevalence of diabetes in Chinese adults. JAMA. 311(2):200. \n                    https:\/\/doi.org\/10.1001\/jama.2013.283127","journal-title":"JAMA"},{"issue":"16","key":"4895_CR15","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","volume":"370","author":"EW Gregg","year":"2014","unstructured":"Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D et al (2014) Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med 370(16):1514\u20131523. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1310799","journal-title":"N Engl J Med"},{"issue":"5","key":"4895_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S2213-8587(18)30027-5","volume":"6","author":"MK Ali","year":"2018","unstructured":"Ali MK, Bullard KM, Saydah S, Imperatore G, Gregg EW (2018) Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014. Lancet Diabetes Endocrinol 6(5):392\u2013403. \n                    https:\/\/doi.org\/10.1016\/S2213-8587(18)30027-5","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"25 Suppl 2","key":"4895_CR17","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","volume":"129","author":"DC Goff Jr","year":"2014","unstructured":"Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D\u2019Agostino RB, Gibbons R et al (2014) 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 129(25 Suppl 2):S49\u2013S73. \n                    https:\/\/doi.org\/10.1161\/01.cir.0000437741.48606.98","journal-title":"Circulation."}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-4895-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-019-4895-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-4895-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T23:04:08Z","timestamp":1590102248000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-019-4895-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,23]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["4895"],"URL":"https:\/\/doi.org\/10.1007\/s00125-019-4895-0","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,23]]},"assertion":[{"value":"28 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KF is funded by the Novo Nordisk Foundation. LP reports personal fees from Novo Nordisk, Merck Astra Zeneca, Boeringer-Ingelheim, Orexigen, Sanofi and Janssen. MK reports research grants from the UK Medical Research Council (K013351, R024227, S011676), NordForsk, Academy of Finland and Helsinki Institute of Life Science during the conduct of the study. MEJ has received research grants from AstraZeneca, AMGEN AB, Sanofi Aventis and Boehringer-Ingelheim (Investigator-initiated research). The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}}]}}